British private equity firm Apax Partners LLP., headquartered in London, England, is set to acquire India’s largest surgical and wound care products maker Healthium Medtech (formerly Sutures India) in a deal estimated at $400 million. San Francisco- and Fort Worth-headquartered private investment firm TPG that held a 73% share in Healthium,...
Global, Indian Companies to Boost Smartphone Adoption in India
Google and India's telecom company Bharti Airtel have partnered to launch low-cost 4G smartphones powered by Android Go, a trimmed down version of Android 8.1 Oreo, in India. Noida-based Lava International Limited and New Delhi-based Micromax, will make the first set of 4G handsets powered by Android Go. Vani Venkatesh, chief...
Siemens Launches Mobile Diagnostic Device in India
Siemens Healthineers, part of the Siemens Group, launched a device that embeds mobile technology with diagnostics in India. "We have signed an exclusive agreement with Jana Care for Aina, a blood monitoring system. It will be the world's first smart phone-based diagnostic system, which will enable detection and management of chronic...
GE Healthcare Awarded 'Indian Medical Device Company of the Year'
At the ‘India Pharmaceutical & India Medical Device 2018’ exhibition and conference that was held from February 15 - 17, 2018 in the southern city of Bangalore, GE Healthcare was announced as the Indian Medical Device Company of the Year for 2018. GE Healthcare was conferred this award for strong...
Global Firms Seek India's IT Talent for Digital Transformation
With technologies such as artificial intelligence and biometrics leading digital transformations in organizations across the world, India is seen as a prime location for global businesses to open technology hubs as an extension of their business rather than a third-party service provider. Bangalore has the best environment for businesses to...
Biocon India Receives US FDA Approval for Biosimilar
India's Bangalore-based Biocon Ltd is the country's first company to have a "biosimilar" approved in the U.S. for Roche’s drug Trastuzumab, marketed as Herceptin, and used in treating certain breast and stomach cancers. Kiran Mazumdar-Shaw, the company’s chairperson and managing director said, "This was the first biosimilar for Herceptin approved...